Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricard Sola

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 12, 2004
The influence of delayed graft functionRicard Sola, Antonio Alarcón, Carlos Jiménez, et al.
Gastroenterologia Y Hepatologia|April 25, 2015
[Hepatitis C treatment in special patient groups]Marina Berenguer, Francisco Jorquera, Miguel Ángel Serra, et al.
HIV Clinical Trials|May 18, 2012
Peginterferon alfa-2a plus ribavirin for HIV-HCV genotype 1 coinfected patients: a randomized international trialMaribel Rodriguez-Torres, Jihad Slim, Laveeza Bhatti, et al.
Brain, Behavior, and Immunity|March 16, 2019
Association of chronic inflammation and perceived stress with abnormal functional connectivity in brain areas involved with interoception in hepatitis C patientsGiovanni Oriolo, Laura Blanco-Hinojo, Ricard Navines, et al.
Hepatology (Baltimore, Md.)|May 27, 2006
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionRichard K Sterling, Eduardo Lissen, Nathan Clumeck, et al.
Plos One|April 1, 2015
Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim studyManuel Romero-Gómez, Juan Turnes, Javier Ampuero, et al.
AIDS (London, England)|July 17, 2007
Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infectionGregory J Dore, Francesca J Torriani, Maribel Rodriguez-Torres, et al.
The New England Journal of Medicine|June 24, 2011
Telaprevir for previously untreated chronic hepatitis C virus infectionIra M Jacobson, John G McHutchison, Geoffrey Dusheiko, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 12, 2004
The influence of delayed graft functionRicard Sola, Antonio Alarcón, Carlos Jiménez, et al.
Gastroenterologia Y Hepatologia|April 25, 2015
[Hepatitis C treatment in special patient groups]Marina Berenguer, Francisco Jorquera, Miguel Ángel Serra, et al.
HIV Clinical Trials|May 18, 2012
Peginterferon alfa-2a plus ribavirin for HIV-HCV genotype 1 coinfected patients: a randomized international trialMaribel Rodriguez-Torres, Jihad Slim, Laveeza Bhatti, et al.
Brain, Behavior, and Immunity|March 16, 2019
Association of chronic inflammation and perceived stress with abnormal functional connectivity in brain areas involved with interoception in hepatitis C patientsGiovanni Oriolo, Laura Blanco-Hinojo, Ricard Navines, et al.
Hepatology (Baltimore, Md.)|May 27, 2006
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionRichard K Sterling, Eduardo Lissen, Nathan Clumeck, et al.
Plos One|April 1, 2015
Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim studyManuel Romero-Gómez, Juan Turnes, Javier Ampuero, et al.
AIDS (London, England)|July 17, 2007
Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infectionGregory J Dore, Francesca J Torriani, Maribel Rodriguez-Torres, et al.
The New England Journal of Medicine|June 24, 2011
Telaprevir for previously untreated chronic hepatitis C virus infectionIra M Jacobson, John G McHutchison, Geoffrey Dusheiko, et al.
Pageof 1